Stephen D Ryder (Stephen Ryder)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 15

Top Topics

High Performance Liquid Chromatography

Immune Response

Atopic Dermatitis

Top Venues

Wellcome open research

Journal of hepatocellular carcinoma

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Robert A Scott, Timothy J S Cross, Christopher G D Clarke, Shahid A Khan, Stephen D Ryder, James Franklin, Aloysious D Aravinthan
Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance. Journal of hepatocellular carcinoma 10 (2023)
Caroline Yeo, Mohsan Subhani, Holly Knight, Katy A Jones, Clare Hutton, Tracey Jackson, Matthew Hutton, Andrew Wragg, Joanne R Morling, Kirsty Sprange, Stephen D Ryder
Transient Elastography and Video Recovery Narrative Access to Support Recovery From Alcohol Misuse: Development of a Novel Intervention for Use in Community Alcohol Treatment Services. JMIR formative research 7 (2023)
Victoria L Mulcahy, Evaggelia Liaskou, Jose-Ezequiel Martin, Prasanti Kotagiri, Jonathan Badrock, Rebecca L Jones, Simon M Rushbrook, Stephen D Ryder, Douglas Thorburn, Simon D Taylor-Robinson, Graeme Clark, Heather J Cordell, Richard N Sandford, David E J Jones, Gideon M Hirschfield, George F Mells
Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells. Hepatology communications 7 (4) (2023)
Laura Martinez-Gili, Alexandros Pechlivanis, Julie Anne Kathryn McDonald, Sofina Begum, Jonathan Badrock, Jessica Katharine Dyson, Rebecca Jones, Gideon M Hirschfield, Stephen D Ryder, Richard Sandford, Simon Rushbrook, Douglas Thorburn, Simon D Taylor-Robinson, Mary M E Crossey, Julian R Marchesi, George Mells, Elaine Holmes, David Jones
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis. Gut microbes 15 (1) (2023)
Laura Martinez-Gili, Alexandros Pechlivanis, Julie Anne Kathryn McDonald, Sofina Begum, Jonathan Badrock, Jessica Katharine Dyson, Rebecca Jones, Gideon M Hirschfield, Stephen D Ryder, Richard Sandford, Simon Rushbrook, Douglas Thorburn, Simon D Taylor-Robinson, Mary M E Crossey, Julian R Marchesi, George Mells, Elaine Holmes, David Jones
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis. Gut microbes 15 (1) (2023)
Robert A Scott, Timothy J S Cross, Christopher G D Clarke, Shahid A Khan, Stephen D Ryder, James Franklin, Aloysious D Aravinthan
Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance. Journal of hepatocellular carcinoma 10 (2023)
Laura Martinez-Gili, Alexandros Pechlivanis, Julie Anne Kathryn McDonald, Sofina Begum, Jonathan Badrock, Jessica Katharine Dyson, Rebecca Jones, Gideon M Hirschfield, Stephen D Ryder, Richard Sandford, Simon Rushbrook, Douglas Thorburn, Simon D Taylor-Robinson, Mary M E Crossey, Julian R Marchesi, George Mells, Elaine Holmes, David Jones
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis. Gut microbes 15 (1) (2023)
Gideon M Hirschfield, Mitchell L Shiffman, Gideon M Hirschfield, Kris V Kowdley, John M Vierling, Cynthia Levy, Andreas E Kremer, Ehud Zigmond, Pietro Andreone, Stuart C Gordon, Christopher L Bowlus, Eric J Lawitz, Richard J Aspinall, Daniel S Pratt, Karina Raikhelson, Maria S Gonzalez-Huezo, Michael A Heneghan, Sook-Hyang Jeong, Alma L Ladrón de Guevara, Marlyn J Mayo, Georgios N Dalekos, Joost Paulus Hubertus Drenth, Ewa Janczewska, Barbara A Leggett, Frederik Nevens, Víctor Vargas, Eli Zuckerman, Christophe Corpechot, Eduardo Fassio, Holger Hinrichsen, Invernizzi Pietro, Palak J Trivedi, Lisa Forman, David E J Jones, Stephen D Ryder, Mark G Swain, Alexandra Steinberg, Pol F Boudes, Yun-Jung Choi, Charles A McWherter, null null
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology (Baltimore, Md.) (2023)
Kushala W M Abeysekera, Ankur Srivastava, Ian Rowe, Helen Jarvis, Stephen D Ryder, Andrew D Yeoman, John F Dillon, William M Rosenberg
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys. Frontline gastroenterology 14 (6) (2023)
Mohsan Subhani, Rebecca Elleray, Jane Bethea, Joanne R Morling, Stephen D Ryder
Alcohol-related liver disease mortality and missed opportunities in secondary care: A United Kingdom retrospective observational study. Drug and alcohol review 41 (6) (2022)
Graham S Cooke, Sarah Pett, Leanne McCabe, Christopher R Jones, Richard Gilson, Sumita Verma, Stephen D Ryder, Jane D Collier, Stephen T Barclay, Aftab Ala, Sanjay Bhagani, Mark Nelson, Chinlye Ch'Ng, Ben Stone, Martin Wiselka, Daniel Forton, McPherson Stuart, Rachel Halford, Dung Nguyen, David Anthony Smith, Azim Ansari, Emily Dennis, Fleur Hudson, Eleanor J Barnes, Ann Sarah Walker
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C. Wellcome open research 6 (2021)
Helen Jarvis, Jonathan Worsfold, Vanessa Hebditch, Stephen D Ryder
Engagement with community liver disease management across the UK: a cross-sectional survey. BJGP open 5 (5) (2021)
Francesco Saverio Mennini, Andrea Marcellusi, Sarah Robbins Scott, Simona Montilla, Loreta A Kondili, Maria Buti Ferret, Liana Gheorghe, Stephen D Ryder, Loreta Anesti Kondili
The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries. Liver international : official journal of the International Association for the Study of the Liver 41 (5) (2021)
Graham S Cooke, Sarah Pett, Leanne McCabe, Christopher R Jones, Richard Gilson, Sumita Verma, Stephen D Ryder, Jane D Collier, Stephen T Barclay, Aftab Ala, Sanjay Bhagani, Mark Nelson, Chinlye Ch'Ng, Ben Stone, Martin Wiselka, Daniel Forton, McPherson Stuart, Rachel Halford, Dung Nguyen, David Anthony Smith, Azim Ansari, Emily Dennis, Fleur Hudson, Eleanor J Barnes, Ann Sarah Walker
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C. Wellcome open research 6 (2021)
Alice Morgan, Sally Hartmanis, Emmanuel A Tsochatzis, Philip Noel Newsome, Stephen D Ryder, Rachel Elliott, Lefteris Floros, Richard Hall, Victoria Higgins, George Stanley, Sandrine Cure, Sharad Vasudevan, Lynne Pezzullo
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018. The European journal of health economics : HEPAC : health economics in prevention and care 22 (4) (2021)